{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:53:25Z","timestamp":1783108405986,"version":"3.54.6"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ecl.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T03:25:16Z","timestamp":1553311516000},"page":"441-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cancer Risk in Transgender People"],"prefix":"10.1016","volume":"48","author":[{"given":"Christel J.M.","family":"de Blok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen M.A.","family":"Dreijerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"den Heijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ecl.2019.02.005_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.ecl.2019.02.005_bib2","first-page":"1359","article-title":"Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer","volume":"40","author":"Huang","year":"2018","journal-title":"Oncol Rep"},{"issue":"11","key":"10.1016\/j.ecl.2019.02.005_bib3","first-page":"1059","article-title":"Differences in cancer survival by sex: a population-based study using cancer registry data","volume":"29","author":"Afshar","year":"2018","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.1016\/j.ecl.2019.02.005_bib4","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.1016\/j.cllc.2018.08.004","article-title":"Sex-dependent staging in non-small-cell lung cancer; analysis of the effect of sex differences in the eighth edition of the tumor, node, metastases staging system","volume":"19","author":"Wainer","year":"2018","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2019.02.005_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1746.2009.05992.x","article-title":"Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer","volume":"25","author":"Koo","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000368418","article-title":"Sex differences of\u00a0>\/= pT1 bladder cancer survival in Austria: a descriptive, long-term, nation-wide analysis based on 27,773 patients","volume":"94","author":"Waldhoer","year":"2015","journal-title":"Urol Int"},{"issue":"5","key":"10.1016\/j.ecl.2019.02.005_bib7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/ATVBAHA.116.307301","article-title":"Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases","volume":"37","author":"Arnold","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.ecl.2019.02.005_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrc1413","article-title":"X-chromosome genetics and human cancer","volume":"4","author":"Spatz","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"10.1016\/j.ecl.2019.02.005_bib9","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1158\/0008-5472.CAN-18-0362","article-title":"Sex differences in cancer driver genes and biomarkers","volume":"78","author":"Li","year":"2018","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ecl.2019.02.005_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2013.01.039","article-title":"Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy","volume":"54","author":"Van Caenegem","year":"2013","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.ecl.2019.02.005_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/EJE-14-0586","article-title":"Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI)","volume":"172","author":"Van Caenegem","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2019.02.005_bib12","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.2105\/AJPH.2012.301002","article-title":"Current tobacco use among adults in the United States: findings from the national adult tobacco survey","volume":"102","author":"King","year":"2012","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1200\/JOP.2017.027714","article-title":"Cancer in transgender patients: one case in 385,820 is indicative of a paucity of data","volume":"14","author":"Cathcart-Rake","year":"2018","journal-title":"J\u00a0Oncol Pract"},{"issue":"1","key":"10.1016\/j.ecl.2019.02.005_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/epirev\/mxw003","article-title":"Cancer in transgender people: evidence and methodological considerations","volume":"39","author":"Braun","year":"2017","journal-title":"Epidemiol Rev"},{"issue":"5","key":"10.1016\/j.ecl.2019.02.005_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ecl.2019.02.005_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2017.01.034","article-title":"Pathological characterisation of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG international male breast cancer program","volume":"82","author":"Vermeulen","year":"2017","journal-title":"Eur J Cancer"},{"issue":"14","key":"10.1016\/j.ecl.2019.02.005_bib17","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ecl.2019.02.005_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11912-014-0427-8","article-title":"Targeting the androgen receptor in breast cancer","volume":"17","author":"Chia","year":"2015","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib19","first-page":"582","article-title":"The Amsterdam cohort of gender dysphoria study (1972-2015): trends in prevalence, treatment, and regrets","volume":"15","author":"Wiepjes","year":"2018","journal-title":"J\u00a0Sex Med"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A\u00a0long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2019.02.005_bib21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0026-0495(89)90233-3","article-title":"Mortality and morbidity in transsexual patients with cross-gender hormone treatment","volume":"9","author":"Asscheman","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2019.02.005_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2019.02.005_bib23","doi-asserted-by":"crossref","first-page":"e16885","DOI":"10.1371\/journal.pone.0016885","article-title":"Long-term follow-up of transsexual persons undergoing sex reassignment surgery: cohort study in Sweden","volume":"6","author":"Dhejne","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2019.02.005_bib25","first-page":"2641","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons","volume":"9","author":"Wierckx","year":"2012","journal-title":"J\u00a0Sex Med"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/lgbt.2014.0050","article-title":"Mortality among veterans with transgender-related diagnoses in the Veterans Health Administration, FY2000-2009","volume":"1","author":"Blosnich","year":"2014","journal-title":"LGBT Health"},{"issue":"10","key":"10.1016\/j.ecl.2019.02.005_bib27","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/and.12208","article-title":"Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens","volume":"46","author":"Gooren","year":"2014","journal-title":"Andrologia"},{"issue":"1","key":"10.1016\/j.ecl.2019.02.005_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-014-3213-2","article-title":"Incidence of breast cancer in a cohort of 5,135 transgender veterans","volume":"149","author":"Brown","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.ecl.2019.02.005_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/lgbt.2015.0058","article-title":"Mental health and medical health disparities in 5135 transgender veterans receiving healthcare in the Veterans Health Administration: a case-control study","volume":"3","author":"Brown","year":"2016","journal-title":"LGBT Health"},{"key":"10.1016\/j.ecl.2019.02.005_bib30","first-page":"p955","article-title":"Breast cancer in transgender people receiving hormone treatment: results of a nationwide cohort study","volume":"56","author":"de Blok","year":"2018","journal-title":"Endocr Abstr"},{"key":"10.1016\/j.ecl.2019.02.005_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.urology.2017.08.032","article-title":"Prostate cancer in transgender women: incidence, etiopathogenesis, and management challenges","volume":"110","author":"Deebel","year":"2017","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.ecl.2019.02.005_bib32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/pros.23322","article-title":"The development of prostate adenocarcinoma in a transgender male to female patient: could estrogen therapy have played a role?","volume":"77","author":"Sharif","year":"2017","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.ecl.2019.02.005_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pros.23446","article-title":"Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression","volume":"78","author":"Bonkhoff","year":"2018","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.ecl.2019.02.005_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/lgbt.2015.0057","article-title":"A\u00a0transgender women with testicular cancer: a new twist on an old problem","volume":"3","author":"Wolf-Gould","year":"2016","journal-title":"LGBT Health"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1677\/ERC-08-0075","article-title":"Epithelial ovarian cancer: testing the 'androgens hypothesis'","volume":"15","author":"Olsen","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rbmo.2009.12.021","article-title":"Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population","volume":"20","author":"Grynberg","year":"2010","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"10.1016\/j.ecl.2019.02.005_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/gyno.1999.5720","article-title":"Ovarian cancer in female-to-male transsexuals: report of two cases","volume":"76","author":"Hage","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000094097","article-title":"Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient","volume":"62","author":"Dizon","year":"2006","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ecl.2019.02.005_bib39","article-title":"Cancer's margins: trans* and gender nonconforming people's access to knowledge, experiences of cancer health, and decision-making","author":"Taylor","year":"2015","journal-title":"LGBT Health"},{"key":"10.1016\/j.ecl.2019.02.005_bib40","article-title":"Adding silver to the rainbow: palliative and end-of-life care for the geriatric LGBTQ patient","author":"Stevens","year":"2018","journal-title":"J\u00a0Palliat Med"},{"issue":"5","key":"10.1016\/j.ecl.2019.02.005_bib41","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ajog.2010.12.057","article-title":"Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance","volume":"204","author":"Urban","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ecl.2019.02.005_bib42","first-page":"2899","article-title":"Vaginal carcinoma in a female-to-male transsexual","volume":"7","author":"Schenck","year":"2010","journal-title":"J\u00a0Sex Med"},{"issue":"5","key":"10.1016\/j.ecl.2019.02.005_bib43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ijir.2013.9","article-title":"Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-alpha and -beta expression of young women","volume":"25","author":"Baldassarre","year":"2013","journal-title":"Int J Impot Res"},{"issue":"1","key":"10.1016\/j.ecl.2019.02.005_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ijir.2012.25","article-title":"Androgen receptor expression in the human vagina under different physiological and treatment conditions","volume":"25","author":"Baldassarre","year":"2013","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ecl.2019.02.005_bib45","first-page":"985","article-title":"Estrogen and progesterone receptors in meningiomas","volume":"60","author":"Cahill","year":"1984","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.ecl.2019.02.005_bib46","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0039-128X(00)00193-8","article-title":"Occurence, regulation, and significance of progesterone receptors in human meningioma","volume":"65","author":"Blankenstein","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.ecl.2019.02.005_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000094307","article-title":"Genesis of prolactinomas: studies using estrogen-treated animals","volume":"35","author":"Sarkar","year":"2006","journal-title":"Front Horm Res"},{"issue":"7","key":"10.1016\/j.ecl.2019.02.005_bib48","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awy108","article-title":"The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment","volume":"141","author":"Nota","year":"2018","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ecl.2019.02.005_bib49","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2125.2011.04031.x","article-title":"Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study","volume":"72","author":"Gil","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.ecl.2019.02.005_bib50","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.ejca.2004.03.022","article-title":"Cervical cancer in a female-to-male trans-sexual","volume":"40","author":"Driak","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ecl.2019.02.005_bib51","article-title":"Prevalence and determinants of anal human papillomavirus infection in men who have sex with men and\u00a0transgender women","author":"Cranston","year":"2018","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/LGT.0000000000000437","article-title":"Prevalence of anal squamous intraepithelial lesions in HIV-1-infected young men who have sex with men and transwomen","volume":"22","author":"Thompson","year":"2018","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib53","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/LGT.0000000000000396","article-title":"Risk factors for anal dysplasia in transgender women: a retrospective chart review","volume":"22","author":"Fein","year":"2018","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"11","key":"10.1016\/j.ecl.2019.02.005_bib54","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/OLQ.0000000000000673","article-title":"Prevalence of anal dysplasia in human immunodeficiency virus-infected transgender women","volume":"44","author":"Kobayashi","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.ecl.2019.02.005_bib55","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1016\/j.ijid.2011.05.007","article-title":"First report on sexually transmitted infections among trans (male to female transvestites, transsexuals, or transgender) and male sex workers in Argentina: high HIV, HPV, HBV, and syphilis prevalence","volume":"15","author":"Dos Ramos Farias","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ecl.2019.02.005_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/sextrans-2014-051987","article-title":"Prevalence of human papillomavirus infection in a clinic sample of transsexuals in Italy","volume":"92","author":"Loverro","year":"2016","journal-title":"Sex Transm Infect"},{"issue":"9","key":"10.1016\/j.ecl.2019.02.005_bib57","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.2105\/AJPH.2018.304560","article-title":"Cancers disproportionately affecting the New York state transgender population, 1979-2016","volume":"108","author":"Hutchison","year":"2018","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.ecl.2019.02.005_bib58","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1097\/LGT.0b013e3182976219","article-title":"Carcinoma of the neovagina after male-to-female reassignment","volume":"18","author":"Fernandes","year":"2014","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"3","key":"10.1016\/j.ecl.2019.02.005_bib59","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/0956462417728856","article-title":"HPV-related squamous cell carcinoma in a neovagina after male-to-female gender confirmation surgery","volume":"29","author":"Bollo","year":"2018","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-8587(16)30319-9","article-title":"Oestrogen and anti-androgen therapy for transgender women","volume":"5","author":"tangpricha","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2019.02.005_bib61","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1055\/s-0037-1606103","article-title":"Breast cancer screening, management, and a review of case study literature in transgender populations","volume":"35","author":"Deutsch","year":"2017","journal-title":"Semin Reprod Med"},{"issue":"3","key":"10.1016\/j.ecl.2019.02.005_bib62","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejrad.2009.03.018","article-title":"Mammography and breast sonography in transsexual women","volume":"74","author":"Weyers","year":"2010","journal-title":"Eur J Radiol"},{"issue":"18","key":"10.1016\/j.ecl.2019.02.005_bib63","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.2018.3712","article-title":"Prostate-specific antigen-based screening for prostate cancer: evidence report and systematic review for the US preventive services task force","volume":"319","author":"Fenton","year":"2018","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.ecl.2019.02.005_bib64","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US preventive services task force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ecl.2019.02.005_bib65","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s11606-015-3462-8","article-title":"Cervical cancer screening for patients on the female-to-male spectrum: a narrative review and guide for clinicians","volume":"30","author":"Potter","year":"2015","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.ecl.2019.02.005_bib66","doi-asserted-by":"crossref","first-page":"e0190172","DOI":"10.1371\/journal.pone.0190172","article-title":"Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients","volume":"13","author":"Reisner","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ecl.2019.02.005_bib67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/lgbt.2016.0142","article-title":"Human papillomavirus-related cancer surveillance, prevention, and screening among transgender men and women: neglected populations at high risk","volume":"4","author":"Brown","year":"2017","journal-title":"LGBT Health"},{"issue":"4","key":"10.1016\/j.ecl.2019.02.005_bib68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/10538720802310733","article-title":"Anal cancer screening: barriers and facilitators among ethnically diverse gay, bisexual, transgender, and other men who have sex with men","volume":"20","author":"Newman","year":"2008","journal-title":"J\u00a0Gay Lesbian Soc Serv"},{"issue":"11","key":"10.1016\/j.ecl.2019.02.005_bib69","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1503\/cmaj.109-4839","article-title":"Screening programs overlook transgender people","volume":"186","author":"Vogel","year":"2014","journal-title":"CMAJ"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852919300106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852919300106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:44:30Z","timestamp":1760175870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852919300106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0889852919300106"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2019.02.005","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer Risk in Transgender People","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}